Charles River Laboratories Intl. Inc vs FirstEnergy Corp. — how do they compare? Charles River Laboratories Intl. Inc trades at $231.21 (market cap $11.14B), while FirstEnergy Corp. trades at $49.5 (market cap $28.01B). The key difference: FirstEnergy Corp. is far larger — about 2.5× Charles River Laboratories Intl. Inc's market cap, and FirstEnergy Corp. pays a 3.84% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals.
| CRL | FE | |
|---|---|---|
Market Cap | $11.14B | $28.01B |
Sector | Health | Utilities |
52-Week High | $233.60 | $51.91 |
52-Week Low | $145.57 | $40.30 |
Enterprise Value | $14.00B | $56.02B |
Dividend Yield | — | 3.84% |
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $229.75, down 1.57% on the day, near its consensus price target of $229.80. The stock shows a bullish technical trend with strong moving average signals and support at $225. Fundamentally, CRL has beaten EPS estimates for three consecutive quarters but reported a net loss of $144.34 million in 2025, with negative profit margins. Recent news highlights collaborations in AI and NGS services, supporting growth prospects.
Outlook remains mixed: analyst consensus is strongly bullish with 72% buy ratings and a high target of $260, but profitability challenges and high P/E of 684.85 pose risks. Cash flow stability and strategic partnerships offer upside, while margin pressures and debt levels require monitoring for sustained recovery.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →FirstEnergy is one of the largest investor-owned utilities in the United States with 10 regulated distribution companies across six mid-Atlantic and Midwestern states. FirstEnergy also owns and operates one of the nation's largest electric transmission systems with 24,000 miles of lines.
Read more on FE →